Pharmaceutical industry groups caution that President Donald Trump’s tariffs on China, Mexico and Canada will likely exacerbate existing drug shortages in the US, raise drug …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Between Walgreens’ earnings call last week and its J.P. Morgan Healthcare Conference presentation on Monday, it’s becoming clear that the company won’t be acquiring anything
Licensing agreement deal values for innovator T-cell receptor (TCR) immunotherapy drugs for European biopharmaceutical companies increased by 325% (by $921 million) between 2023 to 2024
Researchers find that patients with long COVID exhibit moderate-to-severe cognitive slowing compared to controls, highlighting a distinct cognitive signature of post-COVID-19 condition.